Jennifer Tan, MD
Dermatologist, Dermatology Program; Director of Community Health; Director of Teen Acne Program
Assistant Professor of Dermatology, Harvard Medical School
Image
Jennifer Tan, MD
Dermatologist, Dermatology Program; Director of Community Health; Director of Teen Acne Program
Assistant Professor of Dermatology, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Rutgers University
2002
Newark
NJ
Medical School
University of Medicine & Dentistry of NJ, Robert Wood Johnson Medical School
2006
Piscataway
NJ
Internship
Lehigh Valley Hospital
2007
Allentown
PA
Residency
Harvard Medical School Combined Program
2010
Boston
MA
Fellowship
Boston Children's Hospital
2011
Boston
MA
Certifications
American Board of Dermatology (General)
American Board of Dermatology (Pediatric Dermatology)
Publications
Early Features of Progressive Hemifacial Atrophy-Clinical and Imaging Findings. View Abstract
Achieving Equitable Care for People With Disabilities: Considerations for the Dermatologist. View Abstract
COVID-19 and health care disparities: Innovative ways to meet the dermatologic needs of patients experiencing homelessness. View Abstract
Fractional Carbon Dioxide Laser Treatment for Textural Improvement and Symptomatic Relief of Acquired Cutis Laxa of the Neck. View Abstract
Mycoplasma-Induced Rash and Mucositis in a Father and Son: A Case Report. View Abstract
Perspectives on dermatology grand rounds: a survey of United States residency program directors. View Abstract
Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. View Abstract
Boston Health Care for the Homeless Program-Harvard Dermatology Collaboration: A Service-Learning Model Providing Care for an Underserved Population. View Abstract
Part III: cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxa. View Abstract
The Promise Clinic: a service learning approach to increasing access to health care. View Abstract
Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis. View Abstract
Locations